Sheba collaborates with Intel to treat Crohn’s disease

The Sheba Medical Center and Sheba ARC Innovation Center have collaborated with tech giant Intel to create an AI-powered app that analyzes capsule videos from patients’ digestive systems to allow for the early prediction of Crohn’s disease.

The solution’s AI-based algorithm aids clinicians in the identification of Crohn’s symptoms such as inflammation and ulcers, helping to assist in early prediction of disease severity in order to identify treatment needs.

“Predicting the course of the disease in Crohn’s patients is one of the most important clinical challenges in the treatment of inflammatory bowel disease. However, currently available tools are limited and insufficiently accurate,” said Prof. Uri Kopylov, Director of IBD in the Department of Gastroenterology at Sheba.

Whether helping those most in need or advancing healthcare globally:
when you support Sheba, you are making a difference.